Zetia

Former Amgen R&D head Perlmutter to lead research at Merck & Co

It also pulled development of a combination cholesterol therapy based on Januvia (sitagliptin) and atorvastatin; abandoned another cholesterol drug based on Zetia (ezetimibe) and niacin; and suffered a regulatory setback when

Merck settles Vytorin lawsuit for $688m

sales of Vytorin and monotherapy Zetia (ezetimibe) from a level above $5bn in 2007.

Merck blocks Mylan’s generic Zetia and Vytorin after appeal

Zetia (ezetimibe) and Vytorin (ezetimibe/simvastatin), which are approved in the US to reduce cholesterol, are big sellers for Merck, respectively making $2.5bn and $1.7bn during 2012. ... This was later followed by a request for pre-patent approval to

Merck & Co shares fall on Q4 results, osteoporosis drug delay

drug Zetia (ezetimibe) climbed 6 per cent to $676m.

Pfizer files suit against Merck

Pfizer is to sue Merck over the company's plan to launch a Lipitor-plus-Zetia combination pill in the US. ... Merck is aiming to combine a generic version of Lipitor with its Zetia (ezetimibe) product, which also lowers cholesterol but by a different

[ Previous 5 results ] 2 3 4 5 6 7 8 9 [ Next 5 results ]